UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy

Annual review of pharmacology and toxicology, 2021-01, Vol.61 (1), p.225-245

2021

Volltextzugriff (PDF)

A factor VII-based method for the prediction of anticoagulant response to warfarin

Scientific reports, 2018-08, Vol.8 (1), p.12041-12, Article 12041

2018

Volltextzugriff (PDF)

The influence of flip‐flop in population pharmacokinetic analyses

CPT: pharmacometrics and systems pharmacology, 2023-03, Vol.12 (3), p.285-287

2023

Volltextzugriff (PDF)

Impaired response or insufficient dosage?—Examining the potential causes of “inadequate response” to allopurinol in the treatment of gout

Seminars in arthritis and rheumatism, 2014-10, Vol.44 (2), p.170-174

2014

Volltextzugriff (PDF)

Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study

ACR open rheumatology, 2024-07, Vol.6 (7), p.403-411

2024

Volltextzugriff (PDF)

Dabigatran in Patients with Mechanical Heart Valves

The New England journal of medicine, 2014-01, Vol.370 (4), p.381-384

2014

Volltextzugriff (PDF)

Learning More From the Dabigatran Concentrations in the RE-LY Study

Journal of the American College of Cardiology, 2014-06, Vol.63 (24), p.2746-2747

2014

Volltextzugriff (PDF)

Frequency of CYP2C9 polymorphisms in polynesian people and potential relevance to management of gout with benzbromarone

Joint, bone, spine : revue du rhumatisme, 2014-03, Vol.81 (2), p.160-163

2014

Volltextzugriff (PDF)

Nonmedical use of prescription drugs

British journal of clinical pharmacology, 2021-04, Vol.87 (4), p.1635-1636

2021

Volltextzugriff (PDF)

Perspectives on the past, present, and future of pharmacometrics

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1403-1405

2022

Volltextzugriff (PDF)

Medication adherence research comes of age

British journal of clinical pharmacology, 2023-07, Vol.89 (7), p.1914-1917

2023

Volltextzugriff (PDF)

Estimation of adherence to urate‐lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient‐reported dosing

British journal of clinical pharmacology, 2024-05, Vol.90 (5), p.1322-1332

2024

Volltextzugriff (PDF)

Leverage points for establishing clinical decision-maker as a vital component of pharmacists’ professional identity

Research in social and administrative pharmacy, 2024-09, Vol.20 (9), p.954-957

2024

Volltextzugriff (PDF)

Evaluation of designs for renal drug studies based on the European Medicines Agency and Food and Drug Administration guidelines for drugs that are predominantly secreted

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1401-1410

2021

Volltextzugriff (PDF)

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID‐19 (SARS‐COV‐2) treatments

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.707-711

2021

Volltextzugriff (PDF)

Spotlight Commentary: Model‐informed precision dosing must demonstrate improved patient outcomes

British journal of clinical pharmacology, 2019-10, Vol.85 (10), p.2238-2240

2019

Volltextzugriff (PDF)

The development and evaluation of dose‐prediction tools for allopurinol therapy (Easy‐Allo tools)

British journal of clinical pharmacology, 2024-05, Vol.90 (5), p.1268-1279

2024

Volltextzugriff (PDF)

Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpoint

British journal of clinical pharmacology, 2011-06, Vol.71 (6), p.807-814

2011

Volltextzugriff (PDF)

Science fiction has become reality: Best practice for future viral pandemics

British journal of clinical pharmacology, 2021-09, Vol.87 (9), p.3385-3387

2021

Volltextzugriff (PDF)

The Association between Metformin Therapy and Lactic Acidosis

Drug safety, 2019-12, Vol.42 (12), p.1449-1469

2019

Volltextzugriff (PDF)

An allopurinol adherence tool using plasma oxypurinol concentrations

British journal of clinical pharmacology, 2023-07, Vol.89 (7), p.1956-1964

2023

Volltextzugriff (PDF)

The intact nephron hypothesis as a model for renal drug handling

European journal of clinical pharmacology, 2019-02, Vol.75 (2), p.147-156

2019

Volltextzugriff (PDF)

A framework for understanding sources of bias in medication adherence research

British journal of clinical pharmacology, 2023-11, Vol.89 (11), p.3444-3453

2023

Volltextzugriff (PDF)

The propagation of between‐subject variability from dose to response

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1414-1417

2022

Volltextzugriff (PDF)

Kinetic‐pharmacodynamic model for drugs with non‐linear elimination: Parameterisation matters

British journal of clinical pharmacology, 2020-02, Vol.86 (2), p.196-198

2020

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(69)
Buchkapitel
(1)

Sprache

Englisch
(69)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy

A factor VII-based method for the prediction of anticoagulant response to warfarin

The influence of flip‐flop in population pharmacokinetic analyses

Impaired response or insufficient dosage?—Examining the potential causes of “inadequate response” to allopurinol in the treatment of gout

Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study

Dabigatran in Patients with Mechanical Heart Valves

Learning More From the Dabigatran Concentrations in the RE-LY Study

Frequency of CYP2C9 polymorphisms in polynesian people and potential relevance to management of gout with benzbromarone

Nonmedical use of prescription drugs

Perspectives on the past, present, and future of pharmacometrics

Medication adherence research comes of age

Estimation of adherence to urate‐lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient‐reported dosing

Leverage points for establishing clinical decision-maker as a vital component of pharmacists’ professional identity

Evaluation of designs for renal drug studies based on the European Medicines Agency and Food and Drug Administration guidelines for drugs that are predominantly secreted

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID‐19 (SARS‐COV‐2) treatments

Spotlight Commentary: Model‐informed precision dosing must demonstrate improved patient outcomes

The development and evaluation of dose‐prediction tools for allopurinol therapy (Easy‐Allo tools)

Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpoint

Science fiction has become reality: Best practice for future viral pandemics

The Association between Metformin Therapy and Lactic Acidosis

An allopurinol adherence tool using plasma oxypurinol concentrations

The intact nephron hypothesis as a model for renal drug handling

A framework for understanding sources of bias in medication adherence research

The propagation of between‐subject variability from dose to response

Kinetic‐pharmacodynamic model for drugs with non‐linear elimination: Parameterisation matters

Suchergebnisse filtern